Genesis Software

Genesis Therapeutics is an AI-powered biotechnology company focused on discovering and developing small molecule drugs for challenging biological targets. The company utilizes its proprietary G-ENESIS platform, which integrates deep learning, molecular simulation, and high-performance computing to predict drug-target interactions and optimize molecular properties. Genesis targets proteins that have historically been difficult to drug, with a primary focus on oncology, neurology, and inflammatory diseases. The company has secured significant funding from top-tier investors and has entered into strategic collaborations with major pharmaceutical companies like Genentech and Eli Lilly. Genesis is headquartered in Burlingame, California, and was founded by experts in AI and molecular biology from Stanford University.